These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 29398127)

  • 1. Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy.
    Gebhardt BJ; Vargo JA; Ling D; Jones B; Mohney M; Clump DA; Ohr JP; Ferris RL; Heron DE
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):195-200. PubMed ID: 29398127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial Data Pooling for Radiation Dose-Volume Tolerance for Carotid Artery Blowout and Other Bleeding Events in Hypofractionated Head and Neck Retreatments.
    Grimm J; Vargo JA; Mavroidis P; Moiseenko V; Emami B; Jain S; Caudell JJ; Clump DA; Ling DC; Das S; Moros EG; Vinogradskiy Y; Xue J; Heron DE
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):147-159. PubMed ID: 33583641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carotid blowout syndrome in pharyngeal cancer patients treated by hypofractionated stereotactic re-irradiation using CyberKnife: A multi-institutional matched-cohort analysis.
    Yamazaki H; Ogita M; Himei K; Nakamura S; Kotsuma T; Yoshida K; Yoshioka Y
    Radiother Oncol; 2015 Apr; 115(1):67-71. PubMed ID: 25827266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fitting NTCP models to SBRT dose and carotid blowout syndrome data.
    Mavroidis P; Grimm J; Cengiz M; Das S; Tan X; Yazici G; Ozyigit G
    Med Phys; 2018 Oct; 45(10):4754-4762. PubMed ID: 30102783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of carotid blowout after reirradiation of the head and neck: a systematic review.
    McDonald MW; Moore MG; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1083-9. PubMed ID: 21549520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response modeling the risk of carotid bleeding events after stereotactic body radiation therapy for previously irradiated head and neck cancer.
    Ling DC; Vargo JA; Gebhardt BJ; Grimm RJ; Clump DA; Ferris RL; Ohr JP; Heron DE
    J Radiosurg SBRT; 2019; 6(2):83-89. PubMed ID: 31641545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple strategy to decrease fatal carotid blowout syndrome after stereotactic body reirradiaton for recurrent head and neck cancers.
    Yazici G; Sanlı TY; Cengiz M; Yuce D; Gultekin M; Hurmuz P; Yıldız F; Zorlu F; Akyol F; Gurkaynak M; Ozyigit G
    Radiat Oncol; 2013 Oct; 8():242. PubMed ID: 24139288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors.
    Cengiz M; Özyiğit G; Yazici G; Doğan A; Yildiz F; Zorlu F; Gürkaynak M; Gullu IH; Hosal S; Akyol F
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):104-9. PubMed ID: 20675075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 1 Dose Escalation of Stereotactic Body Radiation Therapy and Concurrent Cisplatin for Reirradiation of Unresectable, Recurrent Squamous Cell Carcinoma of the Head and Neck.
    Echevarria MI; Yang GQ; Chen DT; Kirtane K; Russell J; Kish J; Muzaffar J; Otto K; Padhya T; McMullen C; Patel K; Chung CH; Caudell JJ
    Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):341-347. PubMed ID: 37105404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
    Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
    Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4π noncoplanar stereotactic body radiation therapy for head-and-neck cancer: potential to improve tumor control and late toxicity.
    Rwigema JC; Nguyen D; Heron DE; Chen AM; Lee P; Wang PC; Vargo JA; Low DA; Huq MS; Tenn S; Steinberg ML; Kupelian P; Sheng K
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):401-9. PubMed ID: 25482301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis.
    Caudell JJ; Ward MC; Riaz N; Zakem SJ; Awan MJ; Dunlap NE; Isrow D; Hassanzadeh C; Vargo JA; Heron DE; Marcrom S; Boggs DH; Reddy CA; Dault J; Bonner JA; Higgins KA; Beitler JJ; Koyfman SA; Machtay M; Yao M; Trotti AM; Siddiqui F; Lee NY;
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):606-617. PubMed ID: 29413274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon Ion Reirradiation for Recurrent Head and Neck Cancer: A Single-Institutional Experience.
    Held T; Windisch P; Akbaba S; Lang K; El Shafie R; Bernhardt D; Plinkert P; Kargus S; Rieken S; Herfarth K; Debus J; Adeberg S
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):803-811. PubMed ID: 31349059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
    Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
    Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer.
    Vargo JA; Ward MC; Caudell JJ; Riaz N; Dunlap NE; Isrow D; Zakem SJ; Dault J; Awan MJ; Higgins KA; Hassanadeh C; Beitler JJ; Reddy CA; Marcrom S; Boggs DH; Bonner JA; Yao M; Machtay M; Siddiqui F; Trotti AM; Lee NY; Koyfman SA; Ferris RL; Heron DE
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):595-605. PubMed ID: 28899556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interim Results of a Prospective Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Reirradiation Trial for Locally Recurrent Prostate Cancer.
    Bergamin S; Eade T; Kneebone A; Booth J; Hsiao E; Schembri GP; Szymura K; Le A; Kwong C; Brown C; Hunter J; Hruby G
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1172-1178. PubMed ID: 32659332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy.
    Rwigema JC; Heron DE; Ferris RL; Andrade RS; Gibson MK; Yang Y; Ozhasoglu C; Argiris AE; Grandis JR; Burton SA
    Am J Clin Oncol; 2011 Aug; 34(4):372-9. PubMed ID: 20859194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
    Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
    Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.